Viral load and immune response dynamics in patients with haemorrhagic fever with renal syndrome

Clinical Microbiology and Infection

Volumn 19, Issue 8, 2013, Pages

  Korva, M ^a   Saksida, A ^a   Kejzar N ^a   Schmaljohn, C ^b   Avsic Zupanc T ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Cytokines; Dynamic; Hantavirus; Humoral response; Serial samples

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; VIRUS RNA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CYTOKINE RELEASE; DISEASE SEVERITY; DOBRAVA VIRUS; HANTAVIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PUUMALA VIRUS; SLOVENIA; VIREMIA; VIRUS LOAD; VIRUS PATHOGENESIS;

HANTAVIRUS; PUUMALA VIRUS;

EID: 84880511626     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12218     Document Type: Article

References (32)

1. Kruger DH, Schonrich G, Klempa B. Human pathogenic hantaviruses and prevention of infection. Hum Vaccin 2011; 7: 685-693.
2. Cosgriff TM. Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Inf Dis 1991; 13: 97-107.
3. Linderholm M, Elgh F. Clinical characteristics of hantavirus infections on the Eurasian continent. Curr Top Microbiol Immunol 2001; 256: 135-151.
4. Schonrich G, Rang A, Lutteke N, Raftery MJ, Charbonnel N, Ulrich RG. Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev 2008; 225: 163-189.
5. Evander M, Eriksson I, Pettersson L et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol 2007; 45: 2491-2497.
6. Terajima M, Hayasaka D, Maeda K, Ennis FA. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers? Immunol Let 2007; 113: 117-120.
7. Sadeghi M, Eckerle I, Daniel V, Burkhardt U, Opelz G, Schnitzler P. Cytokine expression during early and late phase of acute Puumala hantavirus infection. BMC Immunol 2011; 12: 65.
8. Muranyi W, Bahr U, Zeier M, van der Woude FJ. Hantavirus infection. J Am Soc Nephrol 2005; 16: 3669-3679.
9. Linderholm M, Ahlm C, Settergren B, Waage A, Tarnvik A. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996; 173: 38-43.
10. Saksida A, Wraber B, Avšič-Županc T. Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome. BMC Infect Dis 2011; 11: 142.
11. Markotić A, Dasić G, Gagro A et al. Role of peripheral blood mononuclear cell (PBMC) phenotype changes in the pathogenesis of haemorrhagic fever with renal syndrome (HFRS). Clin Exp Immunol 1999; 115: 329-334.
12. Lindgren T, Ahlm C, Mohamed N, Evander M, Ljunggren HG, Bjorkstrom NK. Longitudinal analysis of the human T cell response during acute hantavirus infection. J Virol 2011; 85: 10252-10260.
13. Avšič-Županc T, Petrovec M, Furlan P, Kaps R, Elgh F, Lundkvist A. Hemorrhagic fever with renal syndrome in the Dolenjska region of Slovenia-a 10-year survey. Clin Infect Dis 1999; 28: 860-865.
14. Pal E, Strle F, Avšič-Županc T. Hemorrhagic fever with renal syndrome in the Pomurje region of Slovenia-an 18-year survey. Wien Klin Wochen 2005; 117: 398-405.
15. Korva M, Saksida A, Kunilo S, Vidan Jeras B, Avšič-Županc T. HLA-associated hemorrhagic fever with renal syndrome disease progression in slovenian patients. Clin Vaccine Immunol 2011; 18:1435-1440.
16. Saksida A. Pomen imunskih dejavnikov in virusnega bremena v patogenezi bunjavirusnih hemoragičnih mrzlic. Faculty of Medicine. Vol. PhD. Ljubljana: University of Ljubljana, 2008; 128.
17. Saksida A, Duh D, Korva M, Avšič-Županc T. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis 2008; 197: 681-685.
18. Korva M, Duh D, Saksida A, Trilar T, Avšič-Županc T. The hantaviral load in tissues of naturally infected rodents. Microbes Infect 2009; 11: 344-351.
19. Team RDC. R: A language and environment for statistical computing. Vienna, Austira: R Foundation for Statistical Computing, 2012.
20. Cleveland W, Grosse E, Shyu W. Local regression models. In: Chambers J, Hastie T, eds. Statistical Models in S, Pacific Grove, CA: Wadsworth & Brooks/Cole, 1992; 309-376
21. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression and Survival Analysis. Springer Series in Statistics. New York, NY: Springer Publishing, 2001; 571 p.
22. Xiao R, Yang S, Koster F, Ye C, Stidley C, Hjelle B. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis 2006; 194: 1403-1409.
23. Terajima M, Hendershot JD IIIrd, Kariwa H et al. High levels of viremia in patients with the Hantavirus pulmonary syndrome. J Infect Dis 1999; 180: 2030-2034.
24. Mustonen J, Partanen J, Kanerva M et al. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kid Inter 1996; 49: 217-221.
25. Makela S, Mustonen J, Ala-Houhala I et al. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis 2002; 186: 843-846.
26. Wang ML, Lai JH, Zhu Y et al. Genetic susceptibility to haemorrhagic fever with renal syndrome caused by Hantaan virus in Chinese Han population. Inter J Immunogen 2009; 36: 227-229.
27. Ferrer CP, Vial CP, Ferres GM et al. Genetic susceptibility to Andes Hantavirus: association between severity of disease and HLA alieles in Chilean patients. Rev Chilena Infectol 2007; 24: 351-359.
28. Maes P, Clement J, Groeneveld PH, Colson P, Huizinga TW, Van Ranst M. Tumor necrosis factor-alpha genetic predisposing factors can influence clinical severity in nephropathia epidemica. Viral Immunol 2006; 19: 558-564.
29. Makela S, Hurme M, Ala-Houhala I et al. Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection. Nephrol Dial Transplant 2001; 16: 1368-1373.
30. Terajima M, Vapalahti O, Van Epps HL, Vaheri A, Ennis FA. Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. Microbes Infect 2004; 6: 238-245.
31. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9: 503-510.
32. Stoltz M, Ahlm C, Lundkvist A, Klingstrom J. Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-gamma-induced nitric oxide production. J Virol 2007; 81: 8685-8691.